Mathias Heikenwalder Selected Research

Amyloidosis

7/2014	Multiple factors contribute to the peripheral induction of cerebral β-amyloidosis.
11/2010	Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.
8/2009	Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mathias Heikenwalder Research Topics

Disease

45	Neoplasms (Cancer) 01/2022 - 04/2010
32	Infections 01/2021 - 01/2003
31	Inflammation (Inflammations) 10/2021 - 02/2005
16	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2009
11	Liver Neoplasms (Liver Cancer) 01/2022 - 05/2010
11	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2011 - 01/2003
10	Neoplasm Metastasis (Metastasis) 09/2021 - 07/2012
8	Scrapie 01/2011 - 01/2004
7	Obesity 11/2021 - 01/2015
5	Non-alcoholic Fatty Liver Disease 01/2022 - 03/2016
5	Virus Diseases (Viral Diseases) 09/2020 - 06/2013
5	Carcinogenesis 01/2020 - 04/2010
5	Liver Diseases (Liver Disease) 12/2019 - 09/2006
5	Colitis 01/2013 - 02/2005
5	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2011 - 07/2004
4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2016
4	Insulin Resistance 12/2020 - 01/2016
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2020 - 10/2014
4	Chronic Hepatitis B 01/2019 - 08/2013
4	Fatty Liver 01/2018 - 10/2016
4	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 09/2009 - 01/2004
3	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 01/2015
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 08/2014
3	Persistent Infection 01/2020 - 01/2013
3	Viremia 01/2020 - 10/2006
3	Chronic Pancreatitis 11/2016 - 12/2007
3	Hepatitis 05/2016 - 10/2009
3	Amyloidosis 07/2014 - 08/2009
3	Alzheimer Disease (Alzheimer's Disease) 07/2014 - 05/2011
2	Dyslipidemias (Dyslipidemia) 11/2021 - 01/2018
2	Hypoxia (Hypoxemia) 10/2021 - 01/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2021 - 01/2020
2	Adenoma (Adenomas) 01/2021 - 01/2016
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2016
2	Leukemia 01/2020 - 11/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 08/2016
2	Cholestasis 01/2020 - 11/2018
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2017 - 06/2010
2	Glucose Intolerance 10/2016 - 01/2016
2	Atherosclerosis 10/2016 - 01/2015
2	Hepatitis B 01/2016 - 03/2014
2	Necrosis 07/2014 - 03/2012
2	Autoimmune Pancreatitis 04/2014 - 11/2012

Drug/Important Bio-Agent (IBA)

19	PrionsIBA 01/2011 - 01/2003
17	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2005
11	CytokinesIBA 01/2021 - 09/2006
8	Lymphotoxin-alpha (Lymphotoxin)IBA 01/2017 - 12/2008
7	ChemokinesIBA 01/2021 - 03/2012
7	Prion ProteinsIBA 08/2009 - 01/2003
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2020 - 05/2010
5	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2011
5	Phosphotransferases (Kinase)IBA 01/2022 - 11/2013
4	Fatty Acids (Saturated Fatty Acids)IBA 11/2021 - 03/2016
4	LigandsIBA 01/2021 - 03/2012
4	Protein Kinases (Protein Kinase)IBA 01/2021 - 11/2013
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019 - 06/2010
3	AntigensIBA 09/2021 - 09/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2012
3	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 01/2020 - 04/2010
3	VaccinesIBA 01/2020 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2008
3	InterferonsIBA 01/2019 - 03/2012
3	LipidsIBA 01/2019 - 01/2016
3	Small Interfering RNA (siRNA)IBA 12/2018 - 01/2016
3	Type I Tumor Necrosis Factor ReceptorsIBA 01/2018 - 06/2008
3	Caspase 8 (Caspase-8)IBA 11/2017 - 08/2013
3	Antiviral Agents (Antivirals)IBA 01/2015 - 08/2013
2	Immune Checkpoint InhibitorsIBA 01/2022 - 09/2021
2	Dietary ProteinsIBA 11/2021 - 01/2018
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2021 - 11/2018
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2021
2	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 01/2020
2	EnzymesIBA 01/2021 - 01/2016
2	AutoantibodiesIBA 11/2020 - 11/2012
2	RNA (Ribonucleic Acid)IBA 10/2020 - 10/2006
2	Inulin FDA Link 01/2020 - 11/2018
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 01/2018
2	Surface Antigens (Surface Antigen)IBA 01/2020 - 05/2016
2	Protein Isoforms (Isoforms)IBA 01/2019 - 08/2009
2	Insulin (Novolin)FDA Link 01/2019 - 01/2016
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2019 - 01/2019
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2019 - 10/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2018 - 08/2016
2	Interferon Type IIBA 01/2018 - 04/2016
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018 - 11/2016
2	CeruletideIBA 11/2016 - 06/2011
2	LipopolysaccharidesIBA 11/2016 - 08/2014
2	Choline (Choline Chloride)IBA 11/2016 - 10/2014
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 05/2016 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2016 - 12/2007
2	Sorafenib (BAY 43-9006)FDA Link 10/2015 - 06/2013
2	Chemokine ReceptorsIBA 01/2015 - 09/2012
2	Amyloid (Amyloid Fibrils)IBA 07/2014 - 11/2010
2	Toll-Like Receptor 3IBA 12/2012 - 03/2012

Therapy/Procedure

20	Therapeutics 01/2022 - 07/2004
4	Injections 01/2019 - 11/2016
2	Immunotherapy 01/2022 - 06/2013
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2016
2	Ligation 01/2017 - 07/2014
2	Liver Transplantation 04/2015 - 12/2014